Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
Search /vufind/Search2/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
PubPharm (129.768)
1
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor : Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer : A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer : Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer : MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer : A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare NSAI (Anastrozole or Letrozole) Plus Abemaciclib, a CDK4 and CDK6 Inhibitor, or Plus Placebo, and to Compare Fulvestrant Plus Abemaciclib or Plus Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer : A Randomized, Double-blind, Placebo Controlled Phase III Study of Darolutamide (ODM-201) Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone Sensitive Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer : A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Asymptomatic or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer : A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Extension Study for the Port Delivery System With Ranibizumab (Portal) : A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) : A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12977]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
129.768
Aufsätze
129.768
E-Artikel
129.768
E-Ressourcen
Zeitschriftentitel
94.296
WHO International Clinical Trials Registry Plat...
35.472
ClinicalTrials.gov
Thema
129.768
610
Phase: Phase 3
129.764
Study Type: Interventional
52.951
Recruitment Status: Not yet recruiting
28.392
Recruitment Status: Completed
23.556
Recruitment Status: Authorised-recruitment may ...
9.760
Recruitment Status: Recruiting
3.144
Recruitment Status: Terminated
2.850
Recruitment Status: Active, not recruiting
2.257
Recruitment Status: Unknown status
1.570
Recruitment Status: Complete: follow-up complete
1.275
Diabetes Mellitus
1.145
Diabetes Mellitus, Type 2
1.006
Recruitment Status: Withdrawn
951
Breast Neoplasms
795
Hypertension
790
Syndrome
765
Carcinoma
692
Recruitment Status: Closed to Recruitment of Pa...
653
Lung Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
80.222
2020-
47.820
2010-2019
1.726
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
127.756
Englisch
1.066
Unbestimmt
622
Spanisch
176
Französisch
52
Deutsch
24
Dänisch
24
Italienisch
6
Niederländisch
6
Portugiesisch
4
Tschechisch
4
Latein
4
Slowakisch
4
Schwedisch
2
Finnisch
2
Galizisch
2
Norwegisch
2
Polnisch
2
Sanskrit
2
Sundanese
2
Tswana
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...